Health System

Study finds that current eligibility criteria are too stringent. If plans lowered the drug-count requirement to the federal minimum of two, MTM eligibility would increase by almost two-thirds.

New Rx, generics, and OTC products for pharmacists

The risk of stroke, heart attack, and death in men taking FDA-approved testosterone products is now under review.

Two oncologists call on ASCO and their peers to support a system that will meet the needs of their patients.

A quality improvement initiative conducted in a primary care setting greatly improved asthma control and outcomes for high-risk adolescents.

Vitamin D has a strong protective effect against the disease process that underlies multiple sclerosis.

40 mg/mL dose of glatiramer acetate injection three times a week will permit a simpler regimen for patients with relapsing forms of MS.

An analysis of emergency department (ED) visits over a 10-year period found that while inappropriate antibiotic use is decreasing in pediatric settings, it continues to remain a problem in adults, according to a study published ahead of print in Antimicrobial Agents and Chemotherapy.

Some people credit ACOs with lowering healthcare costs and improving quality. But a new study reveals that while ACOs are performing well in some areas, they fall woefully short in many others.

The marketplace is flooded with antibacterial hand soaps and body washes that supposedly prevent the spread of bacteria. Problem is, according to the FDA, there’s no evidence that they work.

The direct oral factor Xa inhibitor edoxaban was found to be noninferior to well-managed warfarin for preventing strokes or systemic embolism in patients with atrial fibrillation.

This year’s flu season has been hard on young and middle-aged adults, with most hospitalizations involving patients 18 to 64 years old.

All pregnant women should be screened for gestational diabetes mellitus at 24 weeks gestation, even if they have no symptoms, according to new recommendations from the USPSTF.

Drug shortages are causing medication errors, delayed or cancelled care, and prompting patient complaints, according to a survey of pharmacy directors published in the Journal of Managed Care Pharmacy.

GSK's Mekinist and Tafinlar combination received accelerated approval after priority review.

Now you see it, now you don't . . . the big pharmacy school con

When the cure is killing you, what's wrong with using a drug that actually helps you feel better - and maybe stay alive?

NABP effort seeks worldwide protection for consumers and users of pharmacies online.

As hospitals face decreased reimbursements, pharmacist involvement in pre- and post-discharge medication reconciliation is more important than ever.

The law expands the powers of registered pharmacists and establishes a new category of Advanced Practice Pharmacists.

Patch treating overactive bladder in women is now available OTC.

Since the NECC-triggered outbreak of fungal meningitis in 2012, FDA has responded aggressively, inspected almost 70 pharmacies. Now it is supported by a new law, the DQSA, and many new questions arise.

Portola is pursuing accelerated approval for andexanet alfa and plans to initiate studies on a larger scale in 2014.

Three states prepare to handle mushrooming Medicaid enrollments

Some of the medications coming into Maine will originate in countries where oversight of the pharmaceutical production process is lax or nil. Are the possible consequences worth the probable savings?

A survey of more than 1,000 pharmacists conducted by NCPA reveals high numbers of chronic-pain patients who had to wait or search to fill their prescriptions and pharmacies without supplies to fill them at all.

Two big causes drive NCPA's new president.

Members of the American Pharmacists Association (APhA) will meet the 2014 president-elect candidates during the APhA annual meeting and exhibition in Orlando in March.

Researchers say they have linked high testosterone levels in men to a poor immune response to an influenza vaccine.